Whether disclosure of drug list prices in direct-to-consumer (DTC) TV commercials should be a condition of participation in the US Medicare and Medicaid programs is just one of many issues on which the Trump Administration seeks public comment in its price transparency proposed rule.
The Centers for Medicare and Medicaid Services (CMS), which issued the rule, also is requesting comment on whether wholesale acquisition...